Patents by Inventor Charlotte LEUXE

Charlotte LEUXE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders
    Patent number: 11472807
    Abstract: Compound of formula (I) and its addition salts with pharmaceutically acceptable acids, and methods in which an effective amount of the compound or any pharmaceutically acceptable salt thereof is administered (as a medicament) to an individual in need thereof.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: October 18, 2022
    Assignees: COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, PERHA PHARMACEUTICALS
    Inventors: Aloïse Mabondzo, Charlotte Leuxe, Anne-Cécile Guyot, Nassima Oumata, Laurent Meijer
  • PURINE DERIVATIVES FOR USE AS MEDICAMENT AND FOR USE IN TREATING NEURODEGENERATIVE OR NEURO-INFLAMMATORY DISORDERS
    Publication number: 20200354364
    Abstract: Compound of formula (I) and its addition salts with pharmaceutically acceptable acids, and methods in which an effective amount of the compound or any pharmaceutically acceptable salt thereof is administered (as a medicament) to an individual in need thereof.
    Type: Application
    Filed: April 9, 2018
    Publication date: November 12, 2020
    Applicants: COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, PERHA PHARMACEUTICALS
    Inventors: Aloïse MABONDZO, Charlotte LEUXE, Anne-Cécile GUYOT, Nassima OUMATA, Laurent MEIJER